Catalog #
|
Peptide Name
|
|
|
|
SM231-40
|
Parathyroid Hormone (1-34), human / PTH (1-34), human
|
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-40
|
Parathyroid Hormone (1-34), human / PTH (1-34), human
|
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-50
|
Parathyroid Hormone (39-68), human / PTH (39-68), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH
|
|
|
SM231-50
|
Parathyroid Hormone (39-68), human / PTH (39-68), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH
|
|
|
SM231-55
|
Parathyroid Hormone (39-84), human / PTH (39-84), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys- Ala-Lys-Ser-Gln-OH
|
|
|
SM231-55
|
Parathyroid Hormone (39-84), human / PTH (39-84), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys- Ala-Lys-Ser-Gln-OH
|
|
|
SM231-60
|
Parathyroid Hormone (53-84), human / PTH (53-84), h
|
Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH
|
|
|
SM231-60
|
Parathyroid Hormone (53-84), human / PTH (53-84), h
|
Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH
|
|
|
SM867-10
|
PKA Inhibitor
|
Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2
|
|
|
SM867-10
|
PKA Inhibitor
|
Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2
|
|
|
SM866-25
|
PKA Substrate
|
Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ser-Ile-NH2
|
|
|
SM866-25
|
PKA Substrate
|
Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ser-Ile-NH2
|
|
|
SM875-17
|
Plasminogen Activator Substrate
|
BOC-Val-Gly-Arg-beta-napthyl-amide
|
|
|
SM893-15
|
Prostate Specific Antigen Substrate
|
Morpholinecarbonyl-His-Ser-Ser-Lys-Leu-Gln-7-amino-4(Trifluoromethyl)-coumaride
|
|
|
SM891-15
|
Prostate Specific Antigen Substrate
|
4-Morpholinecarbonyl-His-Ser-Ser-Lys-Leu-Gln-Amino-methylcoumaride
|
|
|
SM890-91
|
Prot. Kin. C Pseudosubstrate Inhibitor
|
Myristoyl-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu-OH
|
|
|
SM890-82
|
Protein Kinase C Substrate
|
Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH
|
|
|
SM871-55
|
Protein Kinase C Substrate from EGF Receptor
|
Lys-Arg-Thr-Leu-Arg-Arg-OH
|
|
|
SM871-55
|
Protein Kinase C Substrate from EGF Receptor
|
Lys-Arg-Thr-Leu-Arg-Arg-OH
|
|
|
SM871-87
|
Protein Kinase Inhibitor Cdk2
|
Tyr-Ser-Phe-Val-His-His-Gly-Phe-Phe-Asn-Phe-Arg-Val-Ser-Trp-Arg-Glu-Met-Leu-Ala-OH
|
|
|
SM871-87
|
Protein Kinase Inhibitor Cdk2
|
Tyr-Ser-Phe-Val-His-His-Gly-Phe-Phe-Asn-Phe-Arg-Val-Ser-Trp-Arg-Glu-Met-Leu-Ala-OH
|
|
|
SM231-43
|
PTH (2-34), human
|
Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-43
|
PTH (2-34), human
|
Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-46
|
PTH (3-34), human
|
Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-46
|
PTH (3-34), human
|
Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-48
|
PTH (4-34), human
|
Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-48
|
PTH (4-34), human
|
Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-51
|
PTH (5-34), human
|
Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-51
|
PTH (5-34), human
|
Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM233-35
|
PTH [Nle8,18,Tyr34] (3-34), amide, bovine Parathyroid Hormone
|
Ser-Glu-Ile-Gln-Phe-050-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-NorLeu-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2
|
|
|
SM233-35
|
PTH [Nle8,18,Tyr34] (3-34), amide, bovine Parathyroid Hormone
|
Ser-Glu-Ile-Gln-Phe-050-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-NorLeu-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2
|
|
|
SM231-85
|
PTH Related protein (1-40) Hypercalcemia Malignancy Factor
|
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-OH
|
|
|
SM231-85
|
PTH Related protein (1-40) Hypercalcemia Malignancy Factor
|
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-OH
|
|
|
SM490-56
|
PYY (3-36), porcine
|
Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
|
|
|
SM490-56
|
PYY (3-36), porcine
|
Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
|
|
|
SM490-11
|
PYY / Peptide YY (3-36), human
|
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
|
|
|
SM490-11
|
PYY / Peptide YY (3-36), human
|
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
|
|
|